Literature DB >> 30255725

Reply: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.

Lin Liang1, David Bin-Chia Wu1, Mohamed Ismail Abdul Aziz1, Raymond Wong2, David Sim3, Kui Toh Gerard Leong4, Yong Quek Wei5, Doreen Tan6, Kwong Ng1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30255725     DOI: 10.1080/13696998.2018.1528979

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


× No keyword cloud information.
  1 in total

1.  Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications.

Authors:  András Incze; Zoltán Kaló; Jaime Espín; Éva Kiss; Sophia Kessabi; Louis P Garrison
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.